Table 1. Autochthonous cases of West Nile virus infection with known clinical manifestations and place of infection reported at NUTS 3 or GAUL 1 level: case number, fatal cases, case fatality by country and year, EU and EU enlargement countries, 2010ā2018 (nā=ā3,849).
EU countries | EU enlargement countries | Total | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Austria | Bulgaria | Croatia | Cyprus | Czechia | France | Greece | Hungary | Italy | Portugal | Romania | Slovenia | Spain | Albania | Montenegro | Serbia | Turkey | Kosovoa | ||||||||||||||||||||||
n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | n | d | ||
2010 | Total | 1 | 0 | NR | NR | 0 | 0 | 0 | 0 | 0 | 0 | 262 | 35 | 18 | 1 | 4 | 0 | NR | 57 | 5 | 0 | 0 | 2 | 0 | NR | NR | NR | 47 | 10 | NR | 391 | 51 | |||||||
WNND | 1 | 0 | NR | NR | 0 | 0 | 0 | 0 | 0 | 0 | 197 | 33 | 16 | 1 | 3 | 0 | NR | 57 | 5 | 0 | 0 | 2 | 0 | NR | NR | NR | 40 | 10 | NR | 316 | 49 | ||||||||
CF WNND | 0% | NR | NA | NA | NA | NA | 17% | 6.3% | 0% | NA | 8.8% | NA | 0% | NA | NA | NA | 25% | NA | 16% | ||||||||||||||||||||
2011 | Total | 0 | 0 | NR | NR | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 9 | 4 | 0 | 18 | 3 | NR | 11 | 1 | 0 | 0 | 0 | 0 | 15 | 0 | NR | NR | 1 | 0 | NR | 149 | 13 | ||||||
WNND | 0 | 0 | NR | NR | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 9 | 4 | 0 | 14 | 3 | NR | 11 | 1 | 0 | 0 | 0 | 0 | 7 | 0 | NR | NR | 1 | 0 | NR | 111 | 13 | |||||||
CF WNND | NA | NR | NA | NA | NA | NA | 12% | 0% | 21% | NA | 9.1% | NA | NA | 0% | NA | NA | 0% | NA | 12% | ||||||||||||||||||||
2012 | Total | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 157 | 17 | 17 | 0 | 45 | 0 | NR | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | NR | 0 | 0 | 241 | 18 | ||
WNND | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 106 | 17 | 8 | 0 | 28 | 0 | NR | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | NR | 0 | 0 | 164 | 18 | |||
CF WNND | NA | NA | 0% | NA | NA | NA | 16% | 0% | 0% | NA | 6.7% | NA | NA | NA | 0% | NA | NA | NA | 11% | ||||||||||||||||||||
2013 | Total | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 85 | 11 | 35 | 1 | 80 | 1 | NR | 24 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | NR | 0 | 0 | 248 | 13 | ||
WNND | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 10 | 32 | 1 | 44 | 1 | NR | 24 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | NR | 0 | 0 | 172 | 12 | |||
CF WNND | NA | NA | 0% | NA | NA | NA | 20% | 3% | 2.3% | NA | 0% | 0% | NA | NA | 0% | NA | NA | NA | 7.0% | ||||||||||||||||||||
2014 | Total | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 6 | 10 | 0 | 24 | 0 | NR | 23 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 77 | 8 | NR | 0 | 0 | 152 | 15 | ||
WNND | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 6 | 6 | 0 | 21 | 0 | NR | 23 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59 | 8 | NR | 0 | 0 | 125 | 15 | |||
CF WNND | 0% | NA | 0% | NA | NA | NA | 43% | 0% | 0% | NA | 4.3% | NA | NA | NA | NA | 14% | NA | NA | 12.0% | ||||||||||||||||||||
2015 | Total | 6 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 18 | 0 | 61 | 0 | 1 | 0 | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 3 | NR | 0 | 0 | 150 | 5 | |
WNND | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 0 | 38 | 0 | 1 | 0 | 32 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 3 | NR | 0 | 0 | 117 | 4 | ||
CF WNND | 0% | NA | 0% | NA | NA | NA | NA | 0% | 0% | 0% | 3.1% | NA | NA | NA | NA | 11% | NA | NA | 3.4% | ||||||||||||||||||||
2016 | Total | 5 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42 | 5 | 76 | 2 | 0 | 0 | 93 | 19 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 44 | 2 | 1 | 1 | 0 | 0 | 268 | 29 |
WNND | 1 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33 | 5 | 39 | 2 | 0 | 0 | 93 | 19 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 41 | 2 | 1 | 1 | 0 | 0 | 213 | 29 | |
CF WNND | 0% | NA | 0% | 0% | NA | NA | NA | 15% | 5% | NA | 20% | NA | 0% | NA | NA | 4.9% | 100% | NA | 14% | ||||||||||||||||||||
2017 | Total | 6 | 0 | 1 | 0 | 5 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 48 | 5 | 20 | 4 | 53 | 1 | 0 | 0 | 66 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 2 | 7 | 1 | 0 | 0 | 257 | 28 |
WNND | 2 | 0 | 1 | 0 | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 5 | 17 | 4 | 26 | 1 | 0 | 0 | 66 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48 | 2 | 4 | 1 | 0 | 0 | 197 | 28 | |
CF WNND | 0% | 0% | 20% | NA | NA | NA | 18% | 24% | 3.8% | NA | 21% | NA | NA | NA | NA | 4.2% | 25% | NA | 14% | ||||||||||||||||||||
2018 | Total | 19 | 0 | 15 | 3 | 57 | 4 | 1 | 0 | 3 | 1 | 27 | 0 | 311 | 51 | 213 | 14 | 610 | 49 | 0 | 0 | 277 | 43 | 4 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 415 | 35 | 26 | 3 | 14 | 3 | 1,993 | 207 |
WNND | 4 | 0 | 13 | 3 | 46 | 4 | 1 | 0 | 3 | 1 | 7 | 0 | 240 | 48 | 152 | 14 | 243 | 49 | 0 | 0 | 277 | 43 | 4 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 368 | 33 | 18 | 3 | 12 | 3 | 1,389 | 202 | |
CF WNND | 0% | 23% | 8.7% | 0% | 33% | 0% | 20% | 9.2% | 20% | NA | 16% | 0% | NA | 100% | NA | 9.0% | 17% | 25% | 15% | ||||||||||||||||||||
Total | Total | 39 | 0 | 19 | 4 | 92 | 5 | 2 | 0 | 3 | 1 | 30 | 0 | 978 | 134 | 377 | 25 | 971 | 56 | 1 | 0 | 598 | 85 | 5 | 0 | 5 | 0 | 16 | 1 | 4 | 0 | 613 | 50 | 82 | 15 | 14 | 3 | 3,849 | 379 |
WNND | 10 | 0 | 14 | 3 | 81 | 5 | 2 | 0 | 3 | 1 | 7 | 0 | 709 | 128 | 284 | 25 | 456 | 56 | 1 | 0 | 598 | 85 | 5 | 0 | 4 | 0 | 8 | 1 | 2 | 0 | 544 | 48 | 64 | 15 | 12 | 3 | 2,804 | 370 | |
CF WNND | 0% | 21% | 6.2% | 0% | 33% | 0% | 18% | 8.8% | 12% | 0% | 14% | 0% | 0% | 13% | 0% | 8.8% | 23% | 25% | 13% |
CF: case fatality; d: deaths; EU: European Union; n: number; GAUL: global administrative unit layers; NA: not applicable; NR: not reported; NUTS: nomenclature of territorial units for statistics; WNND: West Nile neuroinvasive disease.
a This designation is without prejudice to positions on status, and is in line with United Nations Security Council Resolution 1244/99 and the International Court of Justice Opinion on the Kosovo declaration of independence.